Serotonin and dopamine transporter (SERT, DAT) availabilities have prospectively been investigated using [123I]beta-CIT and single photon emission computed tomography in subjects with obsessive-compulsive disorder under treatment with the selective serotonin reuptake inhibitor citalopram. SERT availability decreased by a mean 36.5%, whereas DAT availability increased by about 40%. The data point at a citalopram induced modulation of both serotonergic and dopaminergic activity and support the notion of functional interactions of monoaminergic systems in the human brain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.euroneuro.2005.01.003 | DOI Listing |
Publication Analysis
Top Keywords
sert dat
8
dat availabilities
8
obsessive-compulsive disorder
8
availabilities citalopram
4
citalopram treatment
4
treatment obsessive-compulsive
4
disorder ocd
4
ocd serotonin
4
serotonin dopamine
4
dopamine transporter
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!